Conversion of Th17-type into Th2-type inflammation by acetyl salicylic acid via the adenosine and uric acid pathway in the lung

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 9, 2010, Pages 1093-1103

  Moon, H G ^a   Tae, Y M ^a   Kim, Y S ^a   Gyu Jeon, S ^a   Oh, S Y ^b   Song Gho, Y ^a   Zhu, Z ^b   Kim, Y K ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

acetyl salicylic acid; adenosine; asthma; Th17; Th2

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; ALLOPURINOL; ALUMINUM POTASSIUM SULFATE; EOTAXIN; INTERLEUKIN 13; LIPOPOLYSACCHARIDE; OVALBUMIN; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SENSITIZATION; TH17 CELL; TH2 CELL; UPREGULATION;

ADENOSINE; ALLERGENS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; TH17 CELLS; TH2 CELLS; URIC ACID;

EID: 77955338933     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02352.x     Document Type: Article

References (35)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001 344 : 350 362.
2. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 31 : 143 178.
3. Kim YK, Oh SY, Jeon SG, Park HW, Lee SY, Chun EY et al. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007 178 : 5375 5382.
4. Kim YS, Hong SW, Choi JP, Shin TS, Moon HG, Choi EJ et al. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009 183 : 5113 5120.
5. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971 231 : 232 235.
6. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase-b. Nature 1998 396 : 77 80.
7. Clària J, Serhan C. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995 21 : 9475 9479.
8. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 1997 94 : 2869 2873.
9. Bruce N, Cronstein MCM, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NF-kB. PNAS 1999 96 : 6377 6381.
10. Williams AW, Wilson DM. Uric acid metabolism in humans. Semin Nephrol 1990 10 : 9 14.
11. Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 2006 73 : 1059 1064.
12. Kool M, Soullie T, van Nimwegen M, Willart MA, Muskens F, Jung S et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008 205 : 869 882.
13. Van Arman CG, Carlson R, Risley EA, Thomas RH, Nuss GW. Inhibitory effects of indomethacin, aspirin and certain other drugs on inflammations induced in rat and dog by carrageenan, sodium urate and ellagic acid. J Phamacol Exp Ther 1970 175 : 459 468.
14. Jeon SG, Lee CG, Oh M-H, Chun EY, Gho YS, Cho S-H et al. Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen. challenge. J Allergy Clin Immunol 2007 119 : 831 837.
15. Resta R, Hooker SW, Laurent AB, Jamshedur Rahman SM, Franklin M, Knudsen TB et al. Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5-nucleotidase (CD73). J Clin Invest 1997 99 : 676 683.
16. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL et al. Interleukin-13: central mediator of allergic asthma. Science 1998 282 : 2258 2261.
17. Chohan S, Becker M. Update on emerging urate-lowering therapies. Curr Opin Rheumatol 2008 21 : 143 149.
18. Warner TD, Mitchell JA. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? Proc Natl Acad Sci USA 2002 99 : 13371 13373.
19. Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs 2004 64 : 2417 2432.
20. Morwood K, Gillis D, Smith W, Kette F. Aspirin-sensitive asthma. Intern Med J 2005 35 : 240 246.
21. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 2006 533 : 145 155.
22. Kim SH, Kim YK, Park HW, Jee YK, Kim SH, Bahn JW et al. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 2007 17 : 295 304.
23. Kim SH, Ye YM, Hur GY, Lee SK, Sampson AP, Lee HY et al. CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 2007 8 : 1143 1150.
24. Kim S-H, Kim Y-K, Park H-W, Kim S-H, Kim S-H, Ye Y-M et al. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med 2009 103 : 356 363.
25. Van den Berge M, Kerstjens H, de Reus DM, Koëter GH, Kauffman HF, Postma DS. Provocation with adenosine 5'-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy 2004 34 : 71 76.
26. Boniface K, Bak-Jensen KS, Li Y, Blumenschein WM, McGeachy MJ, McClanahan TK et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J Exp Med 2009 206 : 535 548.
27. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009 15 : 1016 1022.
28. La Vecchia C, Negri E, Franceschi S, Conti E, Montella M, Giacosa A et al. Aspirin and colorectal cancer. Br J Cancer 1997 76 : 675 677.
29. Neugut AI. Aspirin as adjuvant therapy for colorectal cancer: a promising new twist for an old drug. JAMA 2009 302 : 688 689.
30. Brown RA, Spina D, Page CP. Adenosine receptors and asthma. Br J Pharmacol 2008 153 : 5446 5456.
31. Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, Kang MJ et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 2003 112 : 332 344.
32. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997 90 : 1600 1610.
33. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993 148 : 91 97.
34. Chohan S, Becker MA. Update on emerging urate-lowering therapies. Curr Opin Rheumatol 2009 21 : 143 149.
35. Kool M, Pétrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M et al. Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008 181 : 2755 2759.